JP2014511680A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511680A5
JP2014511680A5 JP2014501588A JP2014501588A JP2014511680A5 JP 2014511680 A5 JP2014511680 A5 JP 2014511680A5 JP 2014501588 A JP2014501588 A JP 2014501588A JP 2014501588 A JP2014501588 A JP 2014501588A JP 2014511680 A5 JP2014511680 A5 JP 2014511680A5
Authority
JP
Japan
Prior art keywords
immunoglobulin
variable domain
single variable
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014501588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511680A (ja
JP6181040B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/055499 external-priority patent/WO2012130874A1/en
Publication of JP2014511680A publication Critical patent/JP2014511680A/ja
Publication of JP2014511680A5 publication Critical patent/JP2014511680A5/ja
Application granted granted Critical
Publication of JP6181040B2 publication Critical patent/JP6181040B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014501588A 2011-03-28 2012-03-28 二特異性抗cxcr7免疫グロブリン単一可変ドメイン Expired - Fee Related JP6181040B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161468250P 2011-03-28 2011-03-28
US61/468,250 2011-03-28
US201161540272P 2011-09-28 2011-09-28
US61/540,272 2011-09-28
US201261600263P 2012-02-17 2012-02-17
US61/600,263 2012-02-17
PCT/EP2012/055499 WO2012130874A1 (en) 2011-03-28 2012-03-28 Bispecific anti-cxcr7 immunoglobulin single variable domains

Publications (3)

Publication Number Publication Date
JP2014511680A JP2014511680A (ja) 2014-05-19
JP2014511680A5 true JP2014511680A5 (cg-RX-API-DMAC7.html) 2015-05-07
JP6181040B2 JP6181040B2 (ja) 2017-08-16

Family

ID=45952494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014501588A Expired - Fee Related JP6181040B2 (ja) 2011-03-28 2012-03-28 二特異性抗cxcr7免疫グロブリン単一可変ドメイン

Country Status (7)

Country Link
US (3) US20150158948A9 (cg-RX-API-DMAC7.html)
EP (1) EP2691418A1 (cg-RX-API-DMAC7.html)
JP (1) JP6181040B2 (cg-RX-API-DMAC7.html)
CN (1) CN103917560B (cg-RX-API-DMAC7.html)
AU (1) AU2012234284B2 (cg-RX-API-DMAC7.html)
CA (1) CA2831415A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012130874A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9512236B2 (en) 2006-12-19 2016-12-06 Ablynx N.V. Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
BRPI0911984A2 (pt) 2008-05-16 2016-09-20 Ablynx Nv sequências de aminoácidos direncionadas contra cxcr4 e outros compostos gpcrs compreendendo os mesmos
EP2552962B1 (en) 2010-03-26 2016-03-23 Ablynx N.V. Immunoglobulin single variable domains directed against cxcr7
JP6243850B2 (ja) * 2012-11-26 2017-12-06 学校法人近畿大学 抗がん剤による末梢神経障害の予防、治療、または軽減剤
RS63085B1 (sr) 2014-05-16 2022-04-29 Ablynx Nv Varijabilni domeni imunoglobulina
CA2998343A1 (en) * 2015-09-14 2017-03-23 Galaxy Biotech Llc Highly potent monoclonal antibodies to angiogenic factors
NO2768984T3 (cg-RX-API-DMAC7.html) 2015-11-12 2018-06-09
PL3374392T3 (pl) * 2015-11-13 2022-03-28 Ablynx Nv Ulepszone domeny zmienne immunoglobuliny wiążące albuminę surowicy
SG10201911035QA (en) 2015-11-18 2020-01-30 Merck Sharp & Dohme Pd1 and/or lag3 binders
US10975141B2 (en) * 2016-02-12 2021-04-13 Ablynx N.V. Method for the production of immunoglobulin single variable domains
JP7150618B2 (ja) * 2016-06-23 2022-10-11 アブリンクス エン.ヴェー. 免疫グロブリン単一可変ドメインについての改善された薬物動態アッセイ
US20200392512A1 (en) * 2018-02-26 2020-12-17 Ablynx N.V. Nucleotide sequences encoding peptide linkers
TW202440614A (zh) 2022-12-23 2024-10-16 比利時商艾伯霖克斯公司 基於蛋白質的接合載體
WO2024170756A1 (en) 2023-02-17 2024-08-22 Ablynx N.V. Polypeptides binding to the neonatal fc receptor

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903489A0 (fi) 1988-11-11 1990-07-10 Medical Res Council Ligander med en enda sektion, receptorer innehaollande naemnda ligander, foerfaranden foer deras framstaellning samt anvaendning av liganderna och receptorerna.
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
WO1992002551A1 (en) 1990-08-02 1992-02-20 B.R. Centre Limited Methods for the production of proteins with a desired function
ATE427968T1 (de) 1992-08-21 2009-04-15 Univ Bruxelles Immunoglobuline ohne leichtkette
DE69426527T2 (de) 1993-06-09 2001-08-30 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno, Delft Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen
US6091639A (en) 1993-08-27 2000-07-18 Kabushiki Kaisha Toshiba Non-volatile semiconductor memory device and data programming method
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
EP1469883A2 (en) 1998-02-19 2004-10-27 Xcyte Therapies, Inc. Compositions and methods for regulating lymphocyte activation
WO1999050461A1 (en) 1998-03-30 1999-10-07 Northwest Biotherapeutics, Inc. Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
CA2921260A1 (en) 1999-12-24 2001-06-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US6741957B1 (en) 2000-07-21 2004-05-25 Daimlerchrysler Corporation Analytical tire model for vehicle durability and ride comfort analysis
US7018812B2 (en) 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US7211395B2 (en) 2001-03-09 2007-05-01 Dyax Corp. Serum albumin binding moieties
GB0110029D0 (en) 2001-04-24 2001-06-13 Grosveld Frank Transgenic animal
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
US7253007B2 (en) 2001-11-30 2007-08-07 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7871619B2 (en) 2001-11-30 2011-01-18 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7442512B2 (en) 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
KR100599789B1 (ko) 2001-12-03 2006-07-12 삼성에스디아이 주식회사 방열효율이 향상된 플라즈마 디스플레이 장치 및 그 제조방법
US20050214857A1 (en) 2001-12-11 2005-09-29 Algonomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
WO2003066830A2 (en) 2002-02-08 2003-08-14 Genetastix Corporation Human monoclonal antibodies against membrane proteins
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
EP3299393A1 (en) 2002-11-08 2018-03-28 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
AU2003286002B2 (en) 2002-11-08 2011-06-16 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
GB0228210D0 (en) 2002-12-03 2003-01-08 Babraham Inst Single chain antibodies
CA2507004A1 (en) 2002-12-03 2004-06-17 Celltech R & D Limited Assay for identifying antibody producing cells
US7432330B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
GB0312481D0 (en) 2003-05-30 2003-07-09 Celltech R&D Ltd Antibodies
AU2003264053A1 (en) 2003-08-12 2005-03-10 William M. Yarbrough Treatment for acne vulgaris and method of use
EP1658500B1 (en) 2003-08-20 2012-04-18 UCB Pharma, S.A. Methods for obtaining antibodies
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
WO2006047417A2 (en) 2004-10-21 2006-05-04 University Of Florida Research Foundation, Inc. Detection of cannabinoid receptor biomarkers and uses thereof
EP1871807B1 (en) 2005-02-18 2012-11-28 Dana-Farber Cancer Institute, Inc. Antibodies against cxcr4 and methods of use thereof
ES2434852T3 (es) 2005-04-21 2013-12-17 Chemocentryx, Inc. Anticuerpos que se unen a CCX-CKR2
CN103254309B (zh) 2005-05-18 2017-09-26 埃博灵克斯股份有限公司 针对肿瘤坏死因子α的改进的纳米体TM
RU2433139C2 (ru) * 2005-05-20 2011-11-10 Аблинкс Н.В. Nanobodies tm для лечения заболеваний, опосредованных агрегацией
EP1934259A2 (en) 2005-10-11 2008-06-25 Ablynx N.V. Nanobodies and polypeptides against egfr and igf-ir
WO2007055823A2 (en) 2005-10-28 2007-05-18 Multispan, Inc. Gpcr expressing cell lines and antibodies
EP2314590A1 (en) 2005-11-10 2011-04-27 ChemoCentryx, Inc. Substituted quinolones and methods of use
EP2010568A1 (en) 2006-04-14 2009-01-07 Ablynx N.V. Dp-78-like nanobodies
US20070269422A1 (en) * 2006-05-17 2007-11-22 Ablynx N.V. Serum albumin binding proteins with long half-lives
JP2010500876A (ja) * 2006-08-18 2010-01-14 アブリンクス エン.ヴェー. Il−6媒介性シグナル伝達に関連する疾患及び障害の治療のための、il−6rに指向性を有するアミノ酸配列及びこれを含むポリペプチド
JP2010502208A (ja) 2006-09-08 2010-01-28 アブリンクス エン.ヴェー. 半減期の長い血清アルブミン結合タンパク質
US8088895B2 (en) * 2006-10-18 2012-01-03 Chemocentryx, Inc. Antibodies that bind CXCR7 epitopes
JP4810411B2 (ja) 2006-11-30 2011-11-09 東京応化工業株式会社 処理装置
CA2671581A1 (en) 2006-12-05 2008-06-12 Ablynx N.V. Peptides capable of binding to serum proteins
US9512236B2 (en) 2006-12-19 2016-12-06 Ablynx N.V. Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
WO2008074839A2 (en) 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
CN102089325A (zh) 2008-04-17 2011-06-08 埃博灵克斯股份有限公司 能够结合血清白蛋白的肽,以及包含其的化合物、构建体和多肽
BRPI0911984A2 (pt) 2008-05-16 2016-09-20 Ablynx Nv sequências de aminoácidos direncionadas contra cxcr4 e outros compostos gpcrs compreendendo os mesmos
US9034325B2 (en) 2008-07-22 2015-05-19 Ablynx N.V. Amino acid sequences directed against multitarget scavenger receptors and polypeptides
EP2352764B1 (en) * 2008-10-14 2018-03-28 Ablynx N.V. AMINO ACID SEQUENCES TARGETING HUMAN CD4 and CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN,BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND/OR CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY
CN102257003B (zh) * 2008-12-19 2017-04-05 埃博灵克斯股份有限公司 用于产生针对细胞相关抗原如p2x7、cxcr7或cxcr4的免疫球蛋白的基因免疫
WO2010141986A1 (en) * 2009-06-09 2010-12-16 Mabdesign Pty Ltd Novel antibodies and uses therefor
EP2531523A1 (en) 2010-02-05 2012-12-12 Ablynx N.V. Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
EP2552962B1 (en) * 2010-03-26 2016-03-23 Ablynx N.V. Immunoglobulin single variable domains directed against cxcr7
US20140228223A1 (en) 2010-05-10 2014-08-14 Andreas Gnirke High throughput paired-end sequencing of large-insert clone libraries

Similar Documents

Publication Publication Date Title
JP2014511680A5 (cg-RX-API-DMAC7.html)
JP7453206B2 (ja) 改良された血清アルブミン結合剤
JP2023027258A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP2018521638A5 (cg-RX-API-DMAC7.html)
JP2020500538A5 (cg-RX-API-DMAC7.html)
JP2014526898A5 (cg-RX-API-DMAC7.html)
JP2016529229A5 (cg-RX-API-DMAC7.html)
RU2019118359A (ru) Антитело к cd73 человека
JP2019522961A5 (cg-RX-API-DMAC7.html)
JP2016511277A5 (cg-RX-API-DMAC7.html)
JP2012143232A5 (cg-RX-API-DMAC7.html)
JP2005503789A5 (cg-RX-API-DMAC7.html)
JP2020504101A5 (cg-RX-API-DMAC7.html)
JP2016512551A5 (cg-RX-API-DMAC7.html)
JP2012530496A5 (cg-RX-API-DMAC7.html)
JP2016525545A5 (cg-RX-API-DMAC7.html)
JP2010511388A5 (cg-RX-API-DMAC7.html)
JP2015533795A5 (cg-RX-API-DMAC7.html)
JP2011528902A5 (cg-RX-API-DMAC7.html)
JP2015522252A5 (cg-RX-API-DMAC7.html)
IL295534A (en) Improved immunoglobulin variable domains
JP2010502207A5 (cg-RX-API-DMAC7.html)
JP2015530983A5 (cg-RX-API-DMAC7.html)
NZ602892A (en) Antibodies that bind human cd27 and uses thereof
JP2011514150A5 (cg-RX-API-DMAC7.html)